Thyrotoxic Periodic Paralysis Induced by Dexamethasone

被引:1
作者
Lee, Eun Ju [1 ]
Kim, Tae Kyoon [1 ]
Kwon, Min Jeong [1 ]
Lee, Soon Hee [1 ]
Park, Jeong Hyun [1 ]
机构
[1] Inje Univ, Coll Med, Dept Internal Med, 75 Bokji Ro, Busan 614735, South Korea
关键词
Dexamethasone; Hypokalemia; Paralysis; Thyrotoxicosis;
D O I
10.3803/EnM.2012.27.4.299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyrotoxic periodic paralysis (TPP) is a disease characterized by sudden onset and muscle paralysis. It occurs in the setting of hypokalemia of thyrotoxicosis. Cases of TPP induced by a glucocorticoid such as prednisolone or methylprednisolone have been reported. We report on two patients, each of whom received a dexamethasone injection and subsequently developed TPP. Both patients experienced sudden, flaccid paralysis of both extremities after the injection but recovered completely after receiving a potassium replacement. Laboratory results revealed thyrotoxicosis. The patients were diagnosed with Graves' disease and discharged after receiving treatment with methimazole and propranolol. This report provides the clinical description of TPP induced by dexamethasone injection. These cases suggest that clinicians must consider the presence of hyperthyroid disease in patients who develop acute paralysis after treatment with a glucocorticoid, even in the absence thyrotoxic symptoms. Furthermore, physicians should be aware that TPP can occur even in response to dexamethasone used for treatment of thyrotoxic crisis or Graves' ophthalmopathy.
引用
收藏
页码:299 / 302
页数:4
相关论文
共 10 条
  • [1] Glucocorticoids may trigger attacks in several types of periodic paralysis
    Arzel-Hezode, Marianne
    McGoey, Suzanne
    Sternberg, Damien
    Vicart, Savine
    Eymard, Bruno
    Fontaine, Bertrand
    [J]. NEUROMUSCULAR DISORDERS, 2009, 19 (03) : 217 - 219
  • [2] Atallah Paola, 2007, J Med Liban, V55, P167
  • [3] A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis
    Da Silva, MRD
    Cerutti, JM
    Arnaldi, LAT
    Maciel, RMB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) : 4881 - 4884
  • [4] Hagel Stefan, 2009, Cases J, V2, P7501, DOI 10.4076/1757-1626-2-7501
  • [5] Clinical review: Thyrotoxic periodic paralysis: A diagnostic challenge
    Kung, Annie W. C.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07) : 2490 - 2495
  • [6] Ventricular fibrillation due to severe hypokalemia induced by steroid treatment in a patient with thyrotoxic periodic paralysis
    Miyashita, Yasushi
    Monden, Tsuyoshi
    Yamamoto, Kayo
    Matsumura, Mihoko
    Kawagoe, Nobuaki
    Iwata, Chigusa
    Banba, Nobuyuki
    Hattori, Yoshiyuki
    Kasai, Kikuo
    [J]. INTERNAL MEDICINE, 2006, 45 (01) : 11 - 13
  • [7] 장진혁, 2005, [The Korean Journal of Medicine, 대한내과학회지], V68, P692
  • [8] Thyrotoxic Periodic Paralysis (TPP) in a 28-Year-Old Sudanese Man Started on Prednisone
    Tessier, Joshua J.
    Neu, Stacey K.
    Horning, Kristin K.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2010, 23 (04) : 551 - 554
  • [9] Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men
    Wang Li
    Chen Changsheng
    Fu Jiangfang
    Gao Bin
    Zhang Nanyan
    Li Xiaomiao
    Li Deqiang
    Xing Ying
    Zai Wensong
    Ji Qiuhe
    [J]. ENDOCRINE, 2010, 38 (03) : 386 - 390
  • [10] Thyrotoxic periodic paralysis induced by pulse methylprednisolone
    Wongraoprasert, Somporn
    Buranasupkajorn, Patinut
    Sridama, Vitaya
    Snabboon, Thiti
    [J]. INTERNAL MEDICINE, 2007, 46 (17) : 1431 - 1433